MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction

The HGF/MET signaling pathway is abnormal in numerous cancers including ovarian cancer. MET is expressed in 70% of human cancer and it is overexpressed in 30% of ovarian cases and cancer cell lines. The HGF/MET pathway plays a role in the initiation and progression of ovarian cancer through the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Mhawech-Fauceglia, Paulette, Afkhami, Michelle, Pejovic, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540829/
https://www.ncbi.nlm.nih.gov/pubmed/23320251
http://dx.doi.org/10.1155/2012/960327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540829/
https://www.ncbi.nlm.nih.gov/pubmed/23320251
http://dx.doi.org/10.1155/2012/960327

Ejemplares similares